Correction to: Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study

Affiliations

• ¹ Translational and Clinical Research Institute, Newcastle University, Newcastle-Upon-Tyne, UK. [email protected].
• ² Evidera, London, UK. [email protected].
• ³ Clinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium.
• ⁴ Pharmacoepidemiology Department, Center for Observational and Real-world Evidence, Merck & Co, Inc., Rahway, NJ, USA.
• ⁵ Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
• ⁶ Muscular Dystrophy UK, London, UK.
• ⁷ School of Applied Social Science, University of Brighton, East Sussex, UK.
• ⁸ Erasmus School of Health Policy and Management, and Erasmus Choice Modelling Centre, Erasmus University, Rotterdam, The Netherlands.
• ⁹ Global Patient Safety Department, Eli Lilly & Co., Indianapolis, IN, USA.
• ¹⁰ Janssen Research and Development, Titusville, NJ, USA.
• ¹¹ Translational and Clinical Research Institute, Newcastle University, Newcastle-Upon-Tyne, UK.